author-photo

Paula G. Fraenkel

Beth Israel Deaconess Medical Center
Harvard University

49

Papers

919

Citations

Citation Trend

Filter By

Papers (34) Sort By

Journal Conference Others

Treatment with DC/AML Fusion Vaccine and CD3xCD123 Bi-Specific T-Cell Engager (CD123-CODV-TCE) for Treatment of Acute Myeloid Leukemia

2021 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Pre-clinical development of a novel CD3-CD123 bispecific T-cell engager using cross-over dual-variable domain (CODV) format for acute myeloid leukemia (AML) treatment.

2021 OncoImmunology
Show All
- Source
- Cite
- Save
Citations (0)
Genetic Screens Reveal CCDC115 as a Modulator of Erythroid Iron and Heme Trafficking

2020 American Journal of Hematology
Show All
- Source
- Cite
- Save
Citations (2)
MOLECULAR GENETIC ABNORMALITIES IN THE GENOME OF PATIENTS WITH Ph-NEGATIVE MYELOPROLIFERATIVE NEOPLASIA AFFECTED BY IONIZING RADIATION AS A RESULT OF THE CHORNOBYL NUCLEAR ACCIDENT.

2020
Show All
- Source
- Cite
- Save
Citations (0)
Characteristics of myeloproliferative neoplasms in patients exposed to ionizing radiation following the Chernobyl nuclear accident

2019 American Journal of Hematology
Show All
- Source
- Cite
- Save
Citations (4)
SEQUENCE VARIANTS IN PATIENTS WITH MYELOPROLIFERATIVE NEOPLASMS POTENTIALLY INDUCED BY IONIZING RADIATION DUE TO CHERNOBYL NUCLEAR ACCIDENT

2019
Show All
- Source
- Cite
- Save
Citations (0)
Abstract 3093: Genomic characteristics of myeloproliferative neoplasms in patients exposed to ionizing radiation following the Chernobyl nuclear accident

2018 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Abstract 1785: Pre-clinical development of a novel CD3-CD123 bispecific T-cell engager using Cross-Over-Dual-Variable-Domain (CODV) format for the treatment of acute myeloid leukemia (AML)

2018 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
An open-label, first-in-human, dose escalation study of a novel CD3-CD123 bispecific T-cell engager administered as a single agent by intravenous infusion in patients with relapsed or refractory acute myeloid leukemia, B-cell acute lymphoblastic leukemia, or high risk myelodysplastic syndrome.

2018 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (4)
SPECTRUM OF AFFECTED GENES IN UKRAINIAN PATIENTS WITH PRIMARY MYELOFIBROSIS

2018
Show All
- Source
- Cite
- Save
Citations (0)